Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole
Raymond SY Tang, Justin CY Wu Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong Abstract: Peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD) are not uncommon in elderly patients. Clinical presentation...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/11b3ce88e9e840bc8f134a652868f9a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:11b3ce88e9e840bc8f134a652868f9a4 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:11b3ce88e9e840bc8f134a652868f9a42021-12-02T03:26:42ZManaging peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole1178-1998https://doaj.org/article/11b3ce88e9e840bc8f134a652868f9a42013-10-01T00:00:00Zhttps://www.dovepress.com/managing-peptic-ulcer-and-gastroesophageal-reflux-disease-in-elderly-c-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Raymond SY Tang, Justin CY Wu Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong Abstract: Peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD) are not uncommon in elderly patients. Clinical presentations of these acid-related disorders may be atypical in the geriatric population. Older individuals are at increased risk for poor outcomes in complicated PUD and for development of GERD complications. Multiple risk factors (eg, Helicobacter pylori [HP], use of nonsteroidal anti-inflammatory drugs [NSAIDs], aspirin) contribute to the development of PUD. Recent data has shown that HP-negative, NSAID-negative idiopathic peptic ulcers are on the rise and carry a higher risk of recurrent ulcer bleeding and mortality. Effective management of PUD in the geriatric population relies on identification and modification of treatable risk factors. Elderly patients with GERD often require long-term acid suppressive therapy. Proton pump inhibitors (PPI) including esomeprazole are effective in the treatment of reflux esophagitis, maintenance of GERD symptomatic control, and management of PUD as well as its complications. Potential safety concerns of long-term PPI use have been reported in the literature. Clinicians should balance the risks and benefits before committing elderly patients to long-term PPI therapy. Keywords: elderly patients, peptic ulcer disease, gastroesophageal reflux disease, proton pump inhibitor, esomeprazoleTang RSWu JCDove Medical PressarticleGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 8, Pp 1433-1443 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Geriatrics RC952-954.6 |
spellingShingle |
Geriatrics RC952-954.6 Tang RS Wu JC Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole |
description |
Raymond SY Tang, Justin CY Wu Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong Abstract: Peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD) are not uncommon in elderly patients. Clinical presentations of these acid-related disorders may be atypical in the geriatric population. Older individuals are at increased risk for poor outcomes in complicated PUD and for development of GERD complications. Multiple risk factors (eg, Helicobacter pylori [HP], use of nonsteroidal anti-inflammatory drugs [NSAIDs], aspirin) contribute to the development of PUD. Recent data has shown that HP-negative, NSAID-negative idiopathic peptic ulcers are on the rise and carry a higher risk of recurrent ulcer bleeding and mortality. Effective management of PUD in the geriatric population relies on identification and modification of treatable risk factors. Elderly patients with GERD often require long-term acid suppressive therapy. Proton pump inhibitors (PPI) including esomeprazole are effective in the treatment of reflux esophagitis, maintenance of GERD symptomatic control, and management of PUD as well as its complications. Potential safety concerns of long-term PPI use have been reported in the literature. Clinicians should balance the risks and benefits before committing elderly patients to long-term PPI therapy. Keywords: elderly patients, peptic ulcer disease, gastroesophageal reflux disease, proton pump inhibitor, esomeprazole |
format |
article |
author |
Tang RS Wu JC |
author_facet |
Tang RS Wu JC |
author_sort |
Tang RS |
title |
Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole |
title_short |
Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole |
title_full |
Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole |
title_fullStr |
Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole |
title_full_unstemmed |
Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole |
title_sort |
managing peptic ulcer and gastroesophageal reflux disease in elderly chinese patients – focus on esomeprazole |
publisher |
Dove Medical Press |
publishDate |
2013 |
url |
https://doaj.org/article/11b3ce88e9e840bc8f134a652868f9a4 |
work_keys_str_mv |
AT tangrs managingpepticulcerandgastroesophagealrefluxdiseaseinelderlychinesepatientsndashfocusonesomeprazole AT wujc managingpepticulcerandgastroesophagealrefluxdiseaseinelderlychinesepatientsndashfocusonesomeprazole |
_version_ |
1718401714194743296 |